About Ropinirole Hydrochloride
            
            Class: | Dopamine Agonist  
Use: | Treatment of Parkinson's disease and Restless Legs Syndrome (RLS)  
Adult dose: | Initial dose of 0.25 mg three times daily; may be increased to a maximum of 24 mg/day for Parkinson's disease. For RLS, initial dose of 0.25 mg once daily, may be increased to a maximum of 4 mg/day.  
Pediatric dose: | Safety and efficacy not established in pediatric populations; not recommended for use in children.  
Side effects: | Nausea, dizziness, somnolence, fatigue, halluci
         
        
            
                
                
                    
                        Drug Class
                    
                    Dopamine Agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of Parkinson's disease and Restless Legs Syndrome (RLS)
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: SmithKline Beecham Pharmaceuticals, UNITED KINGDOM
                    
                    
                    Package Size
                    21's Blister
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 101.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 0.25 mg three times daily; may be increased to a maximum of 24 mg/day for Parkinson's disease. For RLS, initial dose of 0.25 mg once daily, may be increased to a maximum of 4 mg/day.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric populations; not recommended for use in children.
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, dizziness, somnolence, fatigue, hallucinations, orthostatic hypotension, and peripheral edema.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to ropinirole or any component of the formulation; severe renal impairment; concurrent use with certain medications (e.g., dopamine antagonists).
         
        
        
            
                Important Warnings
            
            Risk of sudden onset of sleep; may cause or exacerbate compulsive behaviors; monitor for signs of neuroleptic malignant syndrome; caution in patients with cardiovascular disease.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.